As a Scientist–Physician, my interests are focused on identifying the critical mechanisms of repair and regeneration for common age-related optic nerve (ON) and retinal diseases, most particularly nonarteritic anterior ischemic optic neuropathy (NAION) and glaucomas, utilizing both molecular biological and cell biological techniques. My previous (1996-2001) work focus involved differential gene expression in the human fovea and peripheral retina, with a strong interest in mechanisms of aging. This work continues, with a collaborative interest in ARMD. My lab generated the first clinically relevant models of NAION in rodents and nonhuman primates. My work is translational in nature, utilizing cell, molecular biological, and functional analyses, as well as primate, transgenic and knockout rodent models, and human tissues, and I was one of the key developers of the NEIbank-ocular tissue gene identification program. The lab is divided into three main interests: (1) Regenerative approaches to optic nerve recovery. (2) Early neuroprotection for ischemic CNS disease. (3) Neuroimmunomodulation to improve repair after ON ischemic injury and traumatic white matter disease. Our new findings have implications for treatment of anterior optic nerve diseases such as NAION and primary open angle glaucoma (POAG). I utilize statistically robust methods to analyze ganglion cell injury and death.
As a Scientist–Physician, my interests are focused on identifying the critical mechanisms of repair and regeneration for common age-related optic nerve (ON) and retinal diseases, most particularly nonarteritic anterior ischemic optic neuropathy (NAION) and glaucomas, utilizing both molecular biological and cell biological techniques. My previous (1996-2001) work focus involved differential gene expression in the human fovea and peripheral retina, with a strong interest in mechanisms of aging. This work continues, with a collaborative interest in ARMD. My lab generated the first clinically relevant models of NAION in rodents and nonhuman primates. My work is translational in nature, utilizing cell, molecular biological, and functional analyses, as well as primate, transgenic and knockout rodent models, and human tissues, and I was one of the key developers of the NEIbank-ocular tissue gene identification program. The lab is divided into three main interests: (1) Regenerative approaches to optic nerve recovery. (2) Early neuroprotection for ischemic CNS disease. (3) Neuroimmunomodulation to improve repair after ON ischemic injury and traumatic white matter disease. Our new findings have implications for treatment of anterior optic nerve diseases such as NAION and primary open angle glaucoma (POAG). I utilize statistically robust methods to analyze ganglion cell injury and death.